May 11, 2018 *, 60 minutes
11:30 am Eastern (10:30 am Central, 9:30 am Mountain, 8:30 am Pacific)
*this webinar WILL be recorded, but access will require a separate purchase. Recorded webinars are available here for purchase a week after the live webinar has taken place.
Number of CERPs & CNEs
1.0 L CERP and 1.0 CNE* (Pending ANCC Approval)
Laura Borgelt, PharmD
By the end of the webinar, the participate will be able to:
- Describe the prevalence of cannabis use in the pregnant and breastfeeding populations.
- Evaluate the impact of cannabis on the fetus, newborn, and breastfeeding infant.
- Explain communication strategies for discussing cannabis use with patients that are pregnant or lactating.
Dr. Laura Borgelt is an Associate Dean of Administration and Operations at the University of Colorado Skaggs School of Pharmacy and Professor in the Departments of Clinical Pharmacy and Family Medicine at the University of Colorado Anschutz Medical Campus. Dr. Borgelt’s teaching, practice, and research focuses on patient safety and women’s health. Her initial interest in educating providers and patients about medical cannabis started about seven years ago when she was asked clinical questions about its use in pregnant and lactating women. Since that time, she has investigated the potential effectiveness and risks of cannabis in a comprehensive manner and has provided evidence-based presentations to medical, nursing, pharmacy, and patient organizations at the state and national level. She has served on seven different working groups regarding rulemaking in the state of Colorado involving consumer safety and social issues. Through her training and experience, Dr. Borgelt has extensive knowledge of cannabis with regards to its pharmacology, pharmacokinetics, pharmacodynamics, therapeutic effectiveness, and potential risks. Her evidence-based, balanced approach to identifying potential benefits and risks of cannabis is important to determine its appropriate use.